Growth and Trends in the Clinical Molecular Diagnostics Market
The clinical molecular diagnostics market was valued at approximately $5.3 billion in 2023 and is expected to expand to $14.45 billion by 2034, with a compound annual growth rate (CAGR) of 9.54% from 2024 to 2034. This growth is primarily driven by the increasing prevalence of chronic conditions, such as genetic and infectious diseases, advancements in molecular biology research, and ongoing technological innovations in the field.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5323
Leading Companies in the Clinical Molecular Diagnostics Market
Several key players are driving the growth of the clinical molecular diagnostics market, including:
- Abbott Laboratories: A global healthcare company offering a wide range of diagnostic tools and services, including molecular diagnostic solutions for infectious diseases, cancer, and genetic disorders.
- Agilent Technologies, Inc.: A leader in life sciences, Agilent provides diagnostic and laboratory tools, with a strong focus on molecular diagnostics, including products for gene expression analysis and next-generation sequencing.
- Amoy Diagnostics: Specializes in molecular diagnostic products for oncology, infectious diseases, and genetic testing, with a focus on providing solutions for precision medicine.
- Becton, Dickinson and Company (BD): A global provider of medical technologies, BD offers molecular diagnostics tools, particularly in the areas of infectious diseases and cancer detection.
- BioMerieux: A French company that develops and manufactures in vitro diagnostic solutions, BioMerieux is known for its diagnostic tests in microbiology, infectious diseases, and molecular diagnostics.
- Bio-Rad Laboratories: Known for its innovative molecular diagnostic products, Bio-Rad focuses on genetic testing, blood typing, and research reagents, catering to both clinical and research needs.
- CORE Diagnostics: A diagnostics company providing high-quality, specialized molecular diagnostic tests for cancer, infectious diseases, and genetic disorders, with a focus on personalized medicine.
- Myriad Genetics: Specializes in genetic testing and molecular diagnostics, offering tests for oncology, genetic disorders, and women’s health, along with personalized treatment insights.
- Qiagen: A global provider of molecular testing solutions, Qiagen offers a range of diagnostics products for research and clinical laboratories, including PCR and next-generation sequencing tools.
- Quest Diagnostics: A leading provider of diagnostic testing services, Quest Diagnostics offers molecular diagnostic tests for genetic disorders, infectious diseases, and cancer.
- Roche Diagnostics: A pioneer in the field of molecular diagnostics, Roche offers a wide range of diagnostic tests for infectious diseases, oncology, and genetic testing, with a focus on personalized medicine.
- Siemens Healthineers: Specializes in innovative diagnostic technologies, Siemens Healthineers provides molecular diagnostic tools for disease detection, particularly in oncology and infectious diseases.
- Sysmex Corporation: A leader in diagnostic solutions, Sysmex offers molecular diagnostic products for clinical laboratories, particularly in the areas of hematology and infectious disease testing.
- Thermo Fisher Scientific: Known for its wide range of scientific products, Thermo Fisher provides molecular diagnostic tools used in research, clinical diagnostics, and life sciences, including PCR and sequencing technologies.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/core-clinical-molecular-diagnostics-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5323
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
